Irvine Newswire

Comprehensive Real-Time News Feed for Irvine, CA.

Results 1 - 15 of 15 for "u:thestreet.com" in Irvine, CA

  1. Don't Get Stuck Holding Too Much Broadcom Ahead of 4Q EarningsRead the original story w/Photo

    Wednesday | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  2. Broadcom must beat earnings estimates this quarter and guide with confidence. That's a tall order.Read the original story w/Photo

    Wednesday | TheStreet.com

    Will that performance continue? Investors in the chip giant should temper their expectations and start selling. Broadcom stock closed Tuesday at $41.34 , down 1.72%.

    Comment?

  3. Revlon Tender and Sale Called for by Investor Armored WolfRead the original story w/Photo

    Wednesday Jan 7 | TheStreet.com

    "The idea is so compelling that the only explanation for Perelman not tendering for the shares is that he's financially constrained," Armored Wolf LLC managing director Bradd Kern said. "What's less important is whether he wants to sell the company or not.

    Comment?

  4. Broadcom (BRCM) Stock Higher Today After Analyst UpgradeRead the original story w/Photo

    Dec 15, 2014 | TheStreet.com

    Analysts cited the Irvine, CA-based chipmaker's raised guidance and dividend , as well as its stock buyback plan as reasons for the upgrade following the company's Analyst Day last Tuesday. At the event, Broadcom announced a $1 billion share buyback plan and increased its fourth quarter revenue guidance to $2.08 billion to $2.15 billion from $2 billion to $2.15 billion.

    Comment?

  5. Broadcom Races Ahead in 2014 But Are Its Shares About to Run Out of Steam?Read the original story w/Photo

    Dec 3, 2014 | TheStreet.com

    And while the Irvine, Calif., company hit a new 52-week high of $43.35 on Nov. 28 and its shares are up 47.5% year to date, a question investors are likely asking is whether the stock has more room to run. It does.

    Comment?

  6. Broadcom Races Ahead in 2014, But is its Shares About to Run Out of Steam?Read the original story w/Photo

    Dec 3, 2014 | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  7. Bill Ackman Wins Big in Allergan's $66 Billion Actavis DealRead the original story w/Photo

    Nov 17, 2014 | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  8. Allergan's $66 Billion Actavis Deal is Still a Win for Bill AckmanRead the original story w/Photo

    Nov 17, 2014 | TheStreet.com

    Dublin, Ireland-based Actavis announced it was going to acquire Allergan for $219 a share in a deal it expects to close in the second quarter of 2015, according to a Monday statement. As part of the deal, Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock.

    Comment?

  9. Pershing Square is Handed a Partial Win in Allergan CaseRead the original story w/Photo

    Nov 5, 2014 | TheStreet.com

    A California federal court judge on Tuesday handed a win to Bill Ackman's Pershing Square Capital Management LP in its efforts to vote its shares at a special meeting of Allergan Inc. shareholders in December regarding the constitution of the Botox maker's board and whether it should engage in talks with Valeant Pharmaceutical International Inc. At the same time, the ruling does not cast aside the allegation that Valeant and the activist hedge fund might have violated securities laws when the two teamed up to make their bid for Irvine, Calif.-based Allergan.

    Comment?

  10. Here's a Look at the Numbers Behind Boot Barn's Successful IPORead the original story

    Oct 30, 2014 | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  11. Here's a Look at the Numbers Behind Boot Barn's Successful IPORead the original story

    Oct 30, 2014 | TheStreet.com

    The Irvine, Calif.-based retailer's stock, which listed on the New York Stock Exchange, initially rose to a high of $19.39 per share during morning trading. Boot Barn priced its initial public offering of 5 million shares on Wednesday at $16 each, the high end of its range, raising $80 million.

    Comment?

  12. Private Equity-Backed Boot Barn Has Set Terms for its IPORead the original story

    Oct 21, 2014 | TheStreet.com

    Boot Barn Holdings Inc., the Irvine, Calif.-based seller of western and work-related apparel and footwear, set the terms for its initial public offering on Monday, to sell 5 million shares of its common stock with a price range of $14 to $16 per share. At the midpoint of the price range, Boot Barn would raise $75 million.

    Comment?

  13. Allergan OKs Special Shareholder Meeting ConsentsRead the original story

    Sep 5, 2014 | TheStreet.com

    The hedge fund run by Bill Ackman is seeking to hold the meeting to remove six of Allergan's nine incumbent directors. The special meeting, scheduled for Dec. 18, is one tactic being used by the dissident to pressure Irvine, Calif.-based Allergan into accepting Canadian-based Valeant Pharmaceutical International unsolicited $54 billion tender offer -- a deal Pershing Square is backing.

    Comment?

  14. Pershing Square Delivers Votes For Allergan Special Meeting to Push Valeant DealRead the original story

    Aug 25, 2014 | TheStreet.com

    Pershing submitted consents of shareholders representing 31% of Allergan's shareholders, slightly more than the 25% of outstanding shares the activist fund needed to submit to have the meeting take place based on Allergan's bylaws.

    Comment?

  15. Pershing Square Delivers Votes For Allergan Special Meeting to Push Valeant DealRead the original story

    Aug 25, 2014 | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

Irvine Job Listings
View or post Irvine job listings on Topix.
Irvine Real Estate
News, listings, and foreclosures in Irvine from Topix.
Irvine Mortgages
Find mortgage rates in Irvine on Topix.